Ester Del Signore

Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy

Antonio Passaro, Patrizia Mancuso, Sara Gandini et al. · Clinical & Translational Oncology · 2019 · 42 citations

Medicine, Immunology, Oncology +17

Surgery for small cell lung cancer: When and how

Monica Casiraghi, Giulia Sedda, Ester Del Signore et al. · Lung Cancer · 2020 · 40 citations

Medicine, Oncology, Surgery +12

Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy

Flavia Longo, Giovanni Mansueto, Vittoria Lapadula et al. · Supportive Care in Cancer · 2010 · 38 citations

Medicine, Pharmacology, Pharmacotherapy +14

Management of Nonhematologic Toxicities Associated With Different EGFR-TKIs in Advanced NSCLC: A Comparison Analysis

Antonio Passaro, Massimo Di Maïo, Ester Del Signore et al. · Clinical Lung Cancer · 2014 · 33 citations

Pharmacy, Oncology, Pharmacology +13

Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional Survey

Chiara Catania, Gianluca Spitaleri, Ester Del Signore et al. · Frontiers in Oncology · 2020 · 27 citations · Full text

Medicine, Health Policy, Oncology +17